Methylation of estrogen receptor alpha and uses thereof
Document Type
Patent
Publication Date
3-29-2007
Abstract
Methods for diagnosis, prognosis, and treatment of cancer based on the methylation status of the ER-.alpha. gene promoter are disclosed. Methylation of the ER-.alpha. gene promoter is indicative of cancer and unfavorable prognosis. The cancer can be treated with a demethylation agent.
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
Location
United States
Assignee
John Wayne Cancer Institute (Santa Monica, CA)
Family ID
38625489
Serial Number
11/693,673
Tech ID
06-JWCI-017
COinS
Comments
Patent Number: 7,829,283